![PDF] Determination of the Reference Values of the Tumor Marker HE4 in Female Population of Canton Sarajevo | Semantic Scholar PDF] Determination of the Reference Values of the Tumor Marker HE4 in Female Population of Canton Sarajevo | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/f50dc44db73d02a0fdaecab49c845d96479f6e8f/3-Table1-1.png)
PDF] Determination of the Reference Values of the Tumor Marker HE4 in Female Population of Canton Sarajevo | Semantic Scholar
![Human Epididymis Protein 4 (HE4) Is a Secreted Glycoprotein that Is Overexpressed by Serous and Endometrioid Ovarian Carcinomas | Cancer Research Human Epididymis Protein 4 (HE4) Is a Secreted Glycoprotein that Is Overexpressed by Serous and Endometrioid Ovarian Carcinomas | Cancer Research](https://cancerres.aacrjournals.org/content/canres/65/6/2162/F1.large.jpg)
Human Epididymis Protein 4 (HE4) Is a Secreted Glycoprotein that Is Overexpressed by Serous and Endometrioid Ovarian Carcinomas | Cancer Research
![PDF] Determination of the Reference Values of the Tumor Marker HE4 in Female Population of Canton Sarajevo | Semantic Scholar PDF] Determination of the Reference Values of the Tumor Marker HE4 in Female Population of Canton Sarajevo | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/f50dc44db73d02a0fdaecab49c845d96479f6e8f/3-Table2-1.png)
PDF] Determination of the Reference Values of the Tumor Marker HE4 in Female Population of Canton Sarajevo | Semantic Scholar
![Human Epididymis Protein 4 (HE4) mRNA as a Prognostic Marker in Ovarian Tumors in Relation to RMI and CA125 - SciAlert Responsive Version Human Epididymis Protein 4 (HE4) mRNA as a Prognostic Marker in Ovarian Tumors in Relation to RMI and CA125 - SciAlert Responsive Version](https://docsdrive.com/images/academicjournals/ijcr/2015/tab1-2k15-175-185.gif)
Human Epididymis Protein 4 (HE4) mRNA as a Prognostic Marker in Ovarian Tumors in Relation to RMI and CA125 - SciAlert Responsive Version
![Serum HE4 and diagnosis of ovarian cancer in postmenopausal women with adnexal masses - American Journal of Obstetrics & Gynecology Serum HE4 and diagnosis of ovarian cancer in postmenopausal women with adnexal masses - American Journal of Obstetrics & Gynecology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/341f34a2-f65b-449e-a344-6fad5ff7a840/gr1.jpg)
Serum HE4 and diagnosis of ovarian cancer in postmenopausal women with adnexal masses - American Journal of Obstetrics & Gynecology
![Utility of tumor marker HE4 as prognostic factor in endometrial cancer: a single-center controlled study | Semantic Scholar Utility of tumor marker HE4 as prognostic factor in endometrial cancer: a single-center controlled study | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/8b70a57cd9716898f88b908842c5a2d45c933bc4/3-Table1-1.png)
Utility of tumor marker HE4 as prognostic factor in endometrial cancer: a single-center controlled study | Semantic Scholar
![Is HE4 Superior over CA-125 in the Follow-up of Patients with Epithelial Ovarian Cancer? | Bentham Science Is HE4 Superior over CA-125 in the Follow-up of Patients with Epithelial Ovarian Cancer? | Bentham Science](https://www.eurekaselect.com/images/graphical-abstract/cdt/21/10/006.jpg)
Is HE4 Superior over CA-125 in the Follow-up of Patients with Epithelial Ovarian Cancer? | Bentham Science
![Comparison of Serum Human Epididymis Protein 4 with Cancer Antigen 125 as a Tumor Marker in Patients with Malignant and Nonmalignant Diseases J.M. Escudero, - ppt video online download Comparison of Serum Human Epididymis Protein 4 with Cancer Antigen 125 as a Tumor Marker in Patients with Malignant and Nonmalignant Diseases J.M. Escudero, - ppt video online download](https://slideplayer.com/slide/6626598/23/images/3/Introduction+%28cont%E2%80%99d%29.jpg)
Comparison of Serum Human Epididymis Protein 4 with Cancer Antigen 125 as a Tumor Marker in Patients with Malignant and Nonmalignant Diseases J.M. Escudero, - ppt video online download
![PDF] HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases | Semantic Scholar PDF] HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/bb4db523eb74d476a02524b225eb0835b20657d2/6-Table3-1.png)
PDF] HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases | Semantic Scholar
![HE4 tumor marker concentration in neoplastic peritoneal effusion and in peritoneal fluid associated with benign gynecological diseases | Journal of Ovarian Research | Full Text HE4 tumor marker concentration in neoplastic peritoneal effusion and in peritoneal fluid associated with benign gynecological diseases | Journal of Ovarian Research | Full Text](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2F1757-2215-7-22/MediaObjects/13048_2014_Article_240_Fig4_HTML.jpg)
HE4 tumor marker concentration in neoplastic peritoneal effusion and in peritoneal fluid associated with benign gynecological diseases | Journal of Ovarian Research | Full Text
![The biomarker HE4 (WFDC2) promotes a pro-angiogenic and immunosuppressive tumor microenvironment via regulation of STAT3 target genes | Scientific Reports The biomarker HE4 (WFDC2) promotes a pro-angiogenic and immunosuppressive tumor microenvironment via regulation of STAT3 target genes | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-65353-x/MediaObjects/41598_2020_65353_Fig1_HTML.png)
The biomarker HE4 (WFDC2) promotes a pro-angiogenic and immunosuppressive tumor microenvironment via regulation of STAT3 target genes | Scientific Reports
![SciELO - Brasil - A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses A comparison of CA125, HE4, risk ovarian SciELO - Brasil - A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses A comparison of CA125, HE4, risk ovarian](https://minio.scielo.br/documentstore/1980-5322/33NknbMHmXvr6ysnZjDL7Vd/7240101f361005f36d10165d48e3ababed511b16.jpg)